Alert: Rating Upgrade (3/28/25)-Adverum Biotechnologies Inc (NASDAQ: ADVM).

out_logo_500#71587.jpg

Stock Rating Upgrade

Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Adverum Biotechnologies Inc (NASDAQ: ADVM) improved in recent days. ADVM’s current Value Trend Rating is C and the prior Rating was D. Details supporting this higher rating are included in our next report.

out_mm#71587.jpg

Recent Price Action

Adverum Biotechnologies Inc (NASDAQ: ADVM) stock suffered a large decline of -7.1% on 3/28/25. The stock closed at $4.61. This decline was accompanied by normal trading volume. Relative to the market the stock has been extremely weak over the last nine months and has declined -17.7% during the last week.

Current PriceTarget Research Rating

Adverum Biotechnologies has a current Value Trend Rating of C (Low Neutral). This VT Rating improved in recent days from D previously. With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Adverum Biotechnologies has a good Appreciation Score of 79 but a very low Power Rating of 9, producing the Low Neutral Value Trend Rating.

Be the first to comment

Leave a Reply

Your email address will not be published.


*